Metraipolis › archive › dc_fe8e4da697a8
Clinicopathological and Prognostic Significance of TROP2 and HER3 Expression in Early-Stage Cervical Carcinoma — Europe PMC PMID:42739301
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42739301
- DOI
- 10.3390/diagnostics16172871
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T00:03:13.827Z
- SHA-256 of the archived text
7e53de190057e1a674cf166d4391828a9c27e4268dea02f8718197e9fa6bb766- Stable URL of this page
https://metraipolis.com/documento/dc_fe8e4da697a8
How to cite
Clinicopathological and Prognostic Significance of TROP2 and HER3 Expression in Early-Stage Cervical Carcinoma — Europe PMC PMID:42739301 — Europe PMC (en), https://europepmc.org/article/MED/42739301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe8e4da697a8 (Metraipolis archive dc_fe8e4da697a8, sha256 7e53de190057e1a674cf166d4391828a9c27e4268dea02f8718197e9fa6bb766)
BibTeX
@misc{dcfe8e4da697a8,
title = {Clinicopathological and Prognostic Significance of TROP2 and HER3 Expression in Early-Stage Cervical Carcinoma — Europe PMC PMID:42739301},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42739301},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe8e4da697a8; sha256 7e53de190057e1a674cf166d4391828a9c27e4268dea02f8718197e9fa6bb766},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42739301. Agents can read the archived copy with the MCP tool read_document.